TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation
The TMEM127 gene encodes a transmembrane protein of poorly known function that is mutated in pheochromocytomas, neural crest-derived tumors of adrenomedullary cells. Here, we report that, at single-nucleus resolution, TMEM127-mutant tumors share precursor cells and transcription regulatory elements...
Saved in:
Published in | Cell reports (Cambridge) Vol. 42; no. 9; p. 113070 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
26.09.2023
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The TMEM127 gene encodes a transmembrane protein of poorly known function that is mutated in pheochromocytomas, neural crest-derived tumors of adrenomedullary cells. Here, we report that, at single-nucleus resolution, TMEM127-mutant tumors share precursor cells and transcription regulatory elements with pheochromocytomas carrying mutations of the tyrosine kinase receptor RET. Additionally, TMEM127-mutant pheochromocytomas, human cells, and mouse knockout models of TMEM127 accumulate RET and increase its signaling. TMEM127 contributes to RET cellular positioning, trafficking, and lysosome-mediated degradation. Mechanistically, TMEM127 binds to RET and recruits the NEDD4 E3 ubiquitin ligase for RET ubiquitination and degradation via TMEM127 C-terminal PxxY motifs. Lastly, increased cell proliferation and tumor burden after TMEM127 loss can be reversed by selective RET inhibitors in vitro and in vivo. Our results define TMEM127 as a component of the ubiquitin system and identify aberrant RET stabilization as a likely mechanism through which TMEM127 loss-of-function mutations cause pheochromocytoma.
[Display omitted]
•TMEM127 loss of function leads to increased RET surface expression and activation•TMEM127 recruits the NEDD4 E3 ligase to RET and promotes its ubiquitination•NEDD4-mediated RET ubiquitination involves the TMEM127 C terminus•Oncogenesis due to TMEM127 deficiency is responsive to RET inhibition
Guo et al. report that TMEM127 deficiency leads to pheochromocytoma by reducing NEDD4-mediated RET ubiquitination, positioning, and degradation and that the resulting cell proliferation is responsive to RET selective inhibition. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 AUTHOR CONTRIBUTIONS Conceptualization, Q.G., P.L.M.D., and R.C.T.A.; snRNA-seq and bioinformatics, Q.G.; molecular studies, Q.G., Z.-M.C., M.R., H.G.C, M.A.K., W.S., B.N.L., C.E.Z., H.K., M.A.K., S.G., P.E., and Z.Q.; mouse models, Q.G., P.E., and Z.Q.; confocal microscopy, Q.G., G.H.-M., W.S., and E.W.; pathology, Y.D. and F.L.; resources, Q.G., H.C.G., H.L., S.G., R.C.T.A., T.J.W., L.M.M., and P.L.M.D.; writing, Q.G., R.C.T.A., and P.L.M.; supervision, P.L.M.D.; funding acquisition, R.C.T.A. and P.L.M.D. |
ISSN: | 2211-1247 2211-1247 |
DOI: | 10.1016/j.celrep.2023.113070 |